Human milk SIgA binds to botulinum type B 16S toxin and limits toxin adherence on T84 cells

Biochemical and Biophysical Research Communications

Volumn 352, Issue 4, 2007, Pages 867-872

  Matsumura, Takuhiro ^a,b   Fujinaga, Yukako ^a   Jin, Yingji ^a,b   Kabumoto, Yuko ^a   Oguma, Keiji ^b  

^a OSAKA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Botulinum; Botulism; Clostridium; Galactose; Hemagglutinin; Immunoglobulin; Innate immunity; Neurotoxin; Secretory IgA; Toxin

Indexed keywords

BOTULINUM TOXIN B; BOTULINUM TOXIN TYPE B 16S; CARBOHYDRATE; GALACTOSE; HEMAGGLUTININ; MILK PROTEIN; NEUROTOXIN; SECRETORY IMMUNOGLOBULIN;

ARTICLE; BOTULISM; BREAST MILK; CELL ADHESION; CELL STRAIN; CELL STRAIN T84; COMPLEX FORMATION; GASTROINTESTINAL ABSORPTION; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

BOTULINUM TOXINS; CELL LINE, TUMOR; GALACTOSE; HEMAGGLUTININS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; MILK, HUMAN; PROTEIN BINDING;

CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM;

EID: 33845413236     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.11.095     Document Type: Article

References (29)

1. Schiavo G., Matteoli M., and Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80 (2000) 717-766
2. Sakaguchi G., Kosaki S., and Ohishi I. Structure and function of botulinum toxins. Bacterial Protein Toxins (1984), Academic Press, London pp. 435-443
3. Oguma K., Inoue K., Fujinaga Y., Yokota K., Watanabe T., Ohyama T., Takeshi K., and Inoue K. Structure and function of Clostridium botulinum progenitor toxin. J. Toxicol.-Toxin Rev. 18 (1999) 17-34
4. Simpson L.L. Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 167-193
5. Fujinaga Y. Transport of bacterial toxins into target cells: pathways followed by cholera toxin and botulinum progenitor toxin. J. Biochem. (Tokyo) 140 (2006) 155-160
6. Nagler-Anderson C. Man the barrier! Strategic defences in the intestinal mucosa. Nat. Rev. Immunol. 1 (2001) 59-67
7. Kaetzel C.S. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol. Rev. 206 (2005) 83-99
8. Hughes G.J., Reason A.J., Savoy L., Jaton J., and Frutiger-Hughes S. Carbohydrate moieties in human secretory component. Biochim. Biophys. Acta 1434 (1999) 86-93
9. de Oliveira I.R., de Araujo A.N., Bao S.N., and Giugliano L.G. Binding of lactoferrin and free secretory component to enterotoxigenic Escherichia coli. FEMS Microbiol. Lett. 203 (2001) 29-33
10. Wold A.E., Mestecky J., Tomana M., Kobata A., Ohbayashi H., Endo T., and Eden C.S. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect. Immun. 58 (1990) 3073-3077
11. Giugliano L.G., Ribeiro S.T., Vainstein M.H., and Ulhoa C.J. Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli. J. Med. Microbiol. 42 (1995) 3-9
12. Schroten H., Stapper C., Plogmann R., Kohler H., Hacker J., and Hanisch F.G. Fab-independent antiadhesion effects of secretory immunoglobulin A on S-fimbriated Escherichia coli are mediated by sialyloligosaccharides. Infect. Immun. 66 (1998) 3971-3973
13. Boren T., Falk P., Roth K.A., Larson G., and Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262 (1993) 1892-1895
14. Falk P., Roth K.A., Boren T., Westblom T.U., Gordon J.I., and Normark S. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. Proc. Natl. Acad. Sci. USA 90 (1993) 2035-2039
15. Dallas S.D., and Rolfe R.D. Binding of Clostridium difficile toxin A to human milk secretory component. J. Med. Microbiol. 47 (1998) 879-888
16. Mantis N.J., Farrant S.A., and Mehta S. Oligosaccharide side chains on human secretory IgA serve as receptors for ricin. J. Immunol. 172 (2004) 6838-6845
17. Fujinaga Y., Inoue K., Nomura T., Sasaki J., Marvaud J.C., Popoff M.R., Kozaki S., and Oguma K. Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes. FEBS Lett. 467 (2000) 179-183
18. Inoue K., Fujinaga Y., Honke K., Arimitsu H., Mahmut N., Sakaguchi Y., Ohyama T., Watanabe T., and Oguma K. Clostridium botulinum type A haemagglutinin-positive progenitor toxin (HA(+)-PTX) binds to oligosaccharides containing Gal beta1-4GlcNAc through one subcomponent of haemagglutinin (HA1). Microbiology 147 (2001) 811-819
19. Arimitsu H., Inoue K., Sakaguchi Y., Lee J., Fujinaga Y., Watanabe T., Ohyama T., Hirst R., and Oguma K. Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia. Infect. Immun. 71 (2003) 1599-1603
20. Hazes B., and Read R.J. A mosquitocidal toxin with a ricin-like cell-binding domain. Nat. Struct. Biol. 2 (1995) 358-359
21. Sagane Y., Kouguchi H., Watanabe T., Sunagawa H., Inoue K., Fujinaga Y., Oguma K., and Ohyama T. Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination. Biochem. Biophys. Res. Commun. 288 (2001) 650-657
22. Inoue K., Sobhany M., Transue T.R., Oguma K., Pedersen L.C., and Negishi M. Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum. Microbiology 149 (2003) 3361-3370
23. Arndt J.W., Gu J., Jaroszewski L., Schwarzenbacher R., Hanson M.A., Lebeda F.J., and Stevens R.C. The structure of the neurotoxin-associated protein HA33/A from Clostridium botulinum suggests a reoccurring beta-trefoil fold in the progenitor toxin complex. J. Mol. Biol. 346 (2005) 1083-1093
24. Fujinaga Y., Inoue K., Watanabe S., Yokota K., Hirai Y., Nagamachi E., and Oguma K. The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. Microbiology 143 Pt 12 (1997) 3841-3847
25. Fujinaga Y., Inoue K., Watarai S., Sakaguchi Y., Arimitsu H., Lee J.C., Jin Y., Matsumura T., Kabumoto Y., Watanabe T., Ohyama T., Nishikawa A., and Oguma K. Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes. Microbiology 150 (2004) 1529-1538
26. Kojima S., Eguchi H., Ookawara T., Fujiwara N., Yasuda J., Nakagawa K., Yamamura T., and Suzuki K. Clostridium botulinum type A progenitor toxin binds to Intestine-407 cells via N-acetyllactosamine moiety. Biochem. Biophys. Res. Commun. 331 (2005) 571-576
27. Nishikawa A., Uotsu N., Arimitsu H., Lee J.C., Miura Y., Fujinaga Y., Nakada H., Watanabe T., Ohyama T., Sakano Y., and Oguma K. The receptor and transporter for internalization of Clostridium botulinum type C progenitor toxin into HT-29 cells. Biochem. Biophys. Res. Commun. 319 (2004) 327-333
28. Uotsu N., Nishikawa A., Watanabe T., Ohyama T., Tonozuka T., Sakano Y., and Oguma K. Cell internalization and traffic pathway of Clostridium botulinum type C neurotoxin in HT-29 cells. Biochim. Biophys. Acta 1763 (2006) 120-128
29. Mantis N.J., Cheung M.C., Chintalacharuvu K.R., Rey J., Corthesy B., and Neutra M.R. Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J. Immunol. 169 (2002) 1844-1851